Universitetssykehuset Nord-Norge HF

Leczenie i dostęp

• Oferowane terapieKetamina
• Ścieżka dostępuBadanie kliniczne
• Koszt i finansowanie (status wg rejestru)Bezpłatnie w ramach badania klinicznego
• Strona internetowahttps://www.unn.no

O tej placówce

Zestawione na podstawie danych rejestrowych z tej strony.

Universitetssykehuset Nord-Norge HF in Tromsoe, Norway, is listed as a clinical trial site for ketamine. The entry is based on CTIS, the EU Clinical Trials Information System, trial 2023-506052-24-00 — the KeDA trial, a blinded, randomized, active placebo-controlled study of ketamine for combined depression and alcohol use disorder; the sponsor is the University Hospital Of North Norway HF. Access is through trial participation, and treatment is free within the clinical trial; no separate pricing or reimbursement information is recorded. The CTIS public record is the registry source cited by this entry. The record was last verified on 2026-07-29.